Regenesis Biomedical, a medical device company focused on non-drug pain management, announced today commercialization of the new Reprieve by Regenesis device (Reprieve). Reprieve is a home-use shortwave diathermy device and is based on Regenesis' core pulsed electromagnetic energy platform.
"Reprieve allows us to market our therapy for broad pain indications within the Department of Veterans Health Administration (VA), which represents a market that is 16X the size of our current market. Because our new device has a two-treatment applicator option, we are expanding our efforts into the podiatric space with a focus on the treatment of pain associated with diabetic neuropathy." said Regenesis CEO Tom Eisiminger.
Regenesis is a privately held medical device company specializing in the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain and improve quality of life. The company said more than 23,000 patients have treated with Regenesis' safe, non-drug, electromagnetic energy for pain management.
